about
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates.The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin.Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine.Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liverAssessment of the drug metabolism capacity of the liver.Genetically determined oxidation capacity and the disposition of debrisoquine.The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.LC-MS-based metabolomics in drug metabolismDebrisoquine metabolism and genetic predisposition to lung cancer.Potential role of CYP2D6 in the central nervous system.Biotransformation of phencyclidine.Genetic predisposition to lung cancerThe metabolism of debrisoquine in man: (1) regioselectivity of hydroxylation and (2) aberrant oxidative metabolism in two sibling patients with carbimazole-induced agranulocytosis.Genetically determined polymorphisms in drug oxidation.Oxidative metabolism of encainide: polymorphism, pharmacokinetics and clinical considerations.Acute renal failure following collective intoxication by Cortinarius orellanus.Lack of congruence ofS-carboxymethyl-L-cysteine sulphoxidation and debrisoquine 4-hydroxylation in a Caucasian populationMetabolic oxidation phenotypes as markers for susceptibility to lung cancer
P2860
Q33667784-4C86C9ED-420F-4899-B09F-A8305CA49EF2Q34331552-CB787074-FB42-48CA-B409-D9961618FD08Q34409085-3AFF23F4-1E59-493F-8DE0-EC8E56DEDDCEQ34421153-C03AC934-33FD-4180-9B1D-CE30A0204F14Q34450039-368B4F95-70AF-42A0-9C2A-234029064C76Q34511238-FEB729EF-0DFD-4A70-9F18-9853A340714AQ34512389-07261B85-AF89-4961-8C7F-C36E645C23C3Q34843826-4246252C-EBB8-41FD-9EA9-7518290F14EAQ35004902-F5A25CD6-D915-4CFF-B227-DD3647BC4452Q36275152-FB608F86-8ED2-4828-9019-6EFD27B4F057Q36467770-47F5019E-BDC7-40D7-A4DD-BDD26187BACDQ37112464-0C5E57E7-7FFA-42B5-8E75-42C3240DA9CCQ39842697-4D065EDF-9703-4A10-8C2B-E482BA131BA6Q42384248-3904CA5B-FADD-4870-AD4B-EE6D1198CCBEQ43872547-68655FA3-F4D9-45B8-A371-CF2DADDE1256Q44947499-F4B43DCF-A335-4C12-AAA0-301295EF1FF2Q45210463-E3CEC60D-AA01-4976-97DF-64C0C12270AFQ45742539-8114471A-470B-470F-A3F8-63DA6EE88A96Q57638651-CF57C7A4-216F-42F3-A101-C31770620484Q59082319-5CED4F38-938E-4442-B97B-2B87689DD467
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
The metabolism of [14C]-debrisoquine in man.
@en
type
label
The metabolism of [14C]-debrisoquine in man.
@en
prefLabel
The metabolism of [14C]-debrisoquine in man.
@en
P2093
P2860
P1476
The metabolism of [14C]-debrisoquine in man.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1979.TB00930.X
P407
P577
1979-03-01T00:00:00Z